Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -1.15M |
| Operating Income | $ -273.20M | $ -259.66M | $ -224.34M | $ -167.25M | $ -136.00M |
| EBITDA | $ -247.49M | $ -236.62M | $ -213.69M | $ -157.81M | $ -131.59M |
| Net Income | $ -258.75M | $ -245.59M | $ -221.86M | $ -169.07M | $ -146.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 372.34M | $ 373.18M | $ 356.39M | $ 388.74M | $ 482.72M |
| Total Assets | $ 527.70M | $ 566.34M | $ 551.81M | $ 497.02M | $ 590.82M |
| Total Debt | $ 25.50M | $ 25.04M | $ 22.87M | $ 22.60M | $ 61.70M |
| Net Debt | $ -138.14M | $ -30.86M | $ -117.65M | $ -210.09M | $ -235.40M |
| Total Liabilities | $ 64.47M | $ 73.77M | $ 62.12M | $ 42.30M | $ 87.31M |
| Stockholders' Equity | $ 463.23M | $ 492.57M | $ 489.69M | $ 454.72M | $ 503.52M |
| Cash Flow | |||||
| Free Cash Flow | $ -215.59M | $ -211.39M | $ -186.76M | $ -128.88M | $ -103.70M |
| Operating Cash Flow | $ -209.72M | $ -194.92M | $ -178.14M | $ -121.16M | $ -74.64M |
| Investing Cash Flow | $ 131.71M | $ -98.07M | $ -69.33M | $ 18.85M | $ -96.59M |
| Financing Cash Flow | $ 185.74M | $ 208.40M | $ 155.29M | $ 37.68M | $ 282.99M |